These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 704415

  • 1. [Correlations of kinetics of antipyrine, indocyanine green and bromosulfophthalein in healthy subjects and in patients with cardiovascular diseases].
    Adamska-Dyniewska H, Kowalczyk L.
    Pol Tyg Lek; 1978 Jul 17; 33(29):1143-5. PubMed ID: 704415
    [No Abstract] [Full Text] [Related]

  • 2. A case of constitutional indocyanine green excretory defect with abnormal retention of sulfobromophthalein: a new functional disorder?
    Nakamuta M, Katsuda Y, Sakamoto S, Nawata H.
    Am J Gastroenterol; 1992 Jul 17; 87(7):930-1. PubMed ID: 1615960
    [No Abstract] [Full Text] [Related]

  • 3. Disposition of aminopyrine, antipyrine, diazepam, and indocyanine green in patients with liver disease or on anticonvulsant drug therapy: diazepam breath test and correlations in drug elimination.
    Hepner GW, Vesell ES, Lipton A, Harvey HA, Wilkinson GR, Schenker S.
    J Lab Clin Med; 1977 Sep 17; 90(3):440-56. PubMed ID: 894100
    [No Abstract] [Full Text] [Related]

  • 4. [Hepatic elimination of indocyanine green and antipyrine in patients with chronic liver disease].
    Kuntz HD, Meessen D, May B.
    Med Welt; 1982 Jun 25; 33(25):909-10. PubMed ID: 7109938
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Liver capacity in the biotransformation of drugs in patients with chronic circulatory failure (kinetics of antipyrine and indocyanine green)].
    Adamska-Dyniewska H.
    Pol Arch Med Wewn; 1978 Oct 25; 60(4):313-8. PubMed ID: 714726
    [No Abstract] [Full Text] [Related]

  • 8. Hepatic metabolic function in patients receiving long-term methotrexate therapy: comparison with topically treated psoriatics, patient controls and cirrhotics.
    Birnie GG, Fitzsimons CP, Czarnecki D, Cooke A, Scobie G, Brodie MJ.
    Hepatogastroenterology; 1985 Aug 25; 32(4):163-7. PubMed ID: 2865199
    [Abstract] [Full Text] [Related]

  • 9. Nine cases with marked retention of indocyanine green test and normal sulfobromophthalein test without abnormal liver histology: constitutional indocyanine green excretory defect.
    Namihisa T, Nambu M, Kobayashi N, Kuroda H.
    Hepatogastroenterology; 1981 Feb 25; 28(1):6-12. PubMed ID: 7216141
    [Abstract] [Full Text] [Related]

  • 10. Increased sulfobromophthalein clearance in a patient receiving phenobarbital and other anticonvulsant drugs.
    Capron JP, Erlinger S, Feldmann G.
    Gastroenterology; 1975 Sep 25; 69(3):756-60. PubMed ID: 1158094
    [Abstract] [Full Text] [Related]

  • 11. Proceedings: The relationships between liver volume and the disposition of antipyrine and indocyanine green before and after phenobarbitone treatment.
    Branch RA, Halliwell M, Jackson L, Roberts CJ.
    Br J Pharmacol; 1975 Oct 25; 55(2):263P. PubMed ID: 1201403
    [No Abstract] [Full Text] [Related]

  • 12. Beta-adrenoceptor blocking drugs and cytochrome P-450: the influence of propranolol treatment on caffeine, antipyrine, D-glucaric acid and indocyanine green elimination in patients with hepatic disorders.
    Traeger A, Horváth T, Rechenbach C, Jávor T.
    Int J Clin Pharmacol Res; 1986 Oct 25; 6(3):235-9. PubMed ID: 3744626
    [Abstract] [Full Text] [Related]

  • 13. Proceedings: The influence of chronic liver disease on the elimination of d-propranolol, anti-pyrine, and indocyanine green.
    Branch RA, James JA, Read AE.
    Gut; 1974 Oct 25; 15(10):837-8. PubMed ID: 4434964
    [No Abstract] [Full Text] [Related]

  • 14. The relationship between liver volume, antipyrine clearance and indocyanine green clearance before and after phenobarbitone administration in man.
    Roberts CJ, Jackson L, Halliwell M, Branch RA.
    Br J Clin Pharmacol; 1976 Oct 25; 3(5):907-13. PubMed ID: 973986
    [Abstract] [Full Text] [Related]

  • 15. Effects of physical stress on the disposition of drugs eliminated by the liver in man.
    Swartz RD, Sidell FR, Cucinell SA.
    J Pharmacol Exp Ther; 1974 Jan 25; 188(1):1-7. PubMed ID: 4809269
    [No Abstract] [Full Text] [Related]

  • 16. A constitutional unconjugated hyperbilirubinemia combined with indocyanine green intolerance: a new functional disorder?
    Ohkubo H, Okuda K, Iida S.
    Hepatology; 1981 Jan 25; 1(4):319-24. PubMed ID: 7286909
    [Abstract] [Full Text] [Related]

  • 17. Abnormal hepatic transport of indocyanine green in Gilbert's syndrome.
    Martin JF, Vierling JM, Wolkoff AW, Scharschmidt BF, Vergalla J, Waggoner JG, Berk PD.
    Gastroenterology; 1976 Mar 25; 70(3):385-91. PubMed ID: 814028
    [Abstract] [Full Text] [Related]

  • 18. Fractional clearance of bromosulfonephthalein and metabolic clearance of antipyrine. Correlative study in liver diseases.
    Couet C, Brissot P, Messner M, Delamaire D, Gie S, Bourel M.
    Ann Gastroenterol Hepatol (Paris); 1984 Mar 25; 20(1):1-6. PubMed ID: 6529154
    [Abstract] [Full Text] [Related]

  • 19. [Hepatic excretion of exogenous dyes. New observations and prospects].
    Skaunic V.
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1979 Mar 25; 22(4 Suppl):385-491. PubMed ID: 317757
    [No Abstract] [Full Text] [Related]

  • 20. Changes in bromsulphophthalein (BSP) and indocyanin-green (ICG) metabolism in man after barbital induction.
    Gógl A.
    Acta Physiol Acad Sci Hung; 1971 Mar 25; 40(3):367-72. PubMed ID: 5147959
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.